Literature DB >> 15608418

p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure.

Christian Gwosdz1, Vera Balz, Kathrin Scheckenbach, Henning Bier.   

Abstract

p63 and p73 share significant structural and functional homologies with the tumour suppressor p53. Unlike the p53 gene, both encode for several isoforms which vary in their NH2 and COOH termini with variable and, in part, opposed biological functions. The objective of the present study was to analyse the expression profiles of p53 family members in squamous cell carcinomas of the head and neck (HNSCC) and their alterations caused by exposure to the clinically active drug cisplatin. Using multiplex RT-PCR combined with the Southern technique, we determined transcription of p53 family members in 10 established HNSCC cell lines. In the majority of HNSCC, p53 and different p63/p73 isoforms were expressed with cell-line-specific patterns for composition and intensity of transcript expression. Exposure to cisplatin caused multiple alterations in the p63 and p73 profiles suggesting a complex regulation which may influence the sensitivity to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608418     DOI: 10.1159/000082473

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  6 in total

1.  UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.

Authors:  Alice L Tang; Samantha J Hauff; John H Owen; Martin P Graham; Michael J Czerwinski; Jung Je Park; Heather Walline; Silvana Papagerakis; Jay Stoerker; Jonathan B McHugh; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2011-12-13       Impact factor: 3.147

2.  Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus.

Authors:  Abigail I Wald; Elizabeth E Hoskins; Susanne I Wells; Robert L Ferris; Saleem A Khan
Journal:  Head Neck       Date:  2011-04       Impact factor: 3.147

3.  Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.

Authors:  Heather M Walline; Christine M Goudsmit; Jonathan B McHugh; Alice L Tang; John H Owen; Bin T Teh; Erin McKean; Thomas W Glover; Martin P Graham; Mark E Prince; Douglas B Chepeha; Steven B Chinn; Robert L Ferris; Susanne M Gollin; Thomas K Hoffmann; Henning Bier; Ruud Brakenhoff; Carol R Bradford; Thomas E Carey
Journal:  Head Neck       Date:  2017-02-25       Impact factor: 3.147

4.  Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.

Authors:  Randall J Kimple; Paul M Harari; Alexandra D Torres; Robert Z Yang; Benjamin J Soriano; Menggang Yu; Eric A Armstrong; Grace C Blitzer; Molly A Smith; Laurel D Lorenz; Denis Lee; David T Yang; Timothy M McCulloch; Gregory K Hartig; Paul F Lambert
Journal:  Clin Cancer Res       Date:  2012-12-18       Impact factor: 12.531

5.  Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells.

Authors:  Yang Gao; Sumita Trivedi; Robert L Ferris; Kazunori Koide
Journal:  Sci Rep       Date:  2014-08-20       Impact factor: 4.379

6.  The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.

Authors:  Justine De Azevedo; Jana Mourtada; Cyril Bour; Véronique Devignot; Philippe Schultz; Christian Borel; Erwan Pencreach; Georg Mellitzer; Christian Gaiddon; Alain C Jung
Journal:  Cells       Date:  2022-09-14       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.